Keywords: Bayer, Xarelto, Atrial fibrillation, UK, NICE, Cost effectiveness

"NICE" news for Bayer, as UK watchdog backs Xarelto for AF

Article | 23 May 2012

Print This

There was good news today (May 23) for German drug major Bayer (BAYN: DE), when the UK’s drug watchdog, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in